Prior to joining Novavax in 2005, Dr. Singhvi served in a number of positions at Merck & Co., where he helped develop several vaccines, including Zostavax®, the only vaccine on the market to prevent shingles.
In 2010, The Daily Record in Maryland recognized Dr. Singhvi as one of the most influential Marylanders in the healthcare field. In that same year, during Dr. Singhvi's tenure as CEO, Novavax was named as one of the ten most innovative companies in the biotechnology industry by Fast Company magazine. Dr. Singhvi has participated in the Clinton Global Initiative and serves on the Board of Directors of Immunocellular Therapeutics, a US public company working on cancer vaccines.
Dr. Singhvi graduated with a chemical engineering degree from the Indian Institute of Technology (IIT), Kanpur, India, where he was top-ranked chemical engineer in his class. He received both his M.S. and Sc.D degrees in chemical engineering from MIT and an MBA from the Wharton School of the University of Pennsylvania where he graduated as a Palmer Scholar.
ABOUT MLV:MLV is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market (ATM) transaction market. Please visit our website: www.mlvco.com. For further information please contact: Randy Billhardt: (212) 542-5882 ( email@example.com)Member FINRA, SIPC. SOURCE McNicoll, Lewis & Vlak LLC
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV